🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hello WiL members, Our next series of webinars is coming very soon (starting April 16). On behalf of the WiL Steering Committee, we hope you will be able to join us!

Ya está todo listo! (partiendo de buena forma también) #LEx25

❤️

#LEX2025 arranca! Honrado y agradecido por la invitación. 3 días de discusiones con grandes referentes de LATAM, Colombia y EEUU. Gracias Daniel Ernst Joaquín Díaz-Schmidt Nicolás Triantafilo Guilherme Perini, MD Matthew Mei y a todo el equipo Lex. Aprender es mejor con amigos!

Partimos! La Dra. Carolina Mahuad Carolina Mahuad hace el recuento de que pasó en Linfomas el año 2024! #LEx25

Lymphoma Experience

Linfoma de Hodgkin R/R, desafíos. Allo TPH aún vigente? Cuando ? El genio de Erratum: This is the wrong web site Mai en su perfecto español! Lymphoma Experience

Kick off #LEX2025 con el bloque educacional. Un honor haber discutido el manejo del linfoma folicular de baja carga tumoral con colegas y amigos. “Si no nos animamos a observar a algunos, probablemente sobretrataremos a muchos”

Lymphoma Experience took a great step by incentivizing us to discuss what the standards in Latin America should be. It is amazing to witness the efforts of colleagues across the world in bringing the best care to patients. Congrats on an amazing conference! Joaquín Díaz-Schmidt Daniel Ernst

LEx es mucho más que una de las mejores conferencias en linfomas de LATAM: lugar de encuentro y aprendizaje permanente entre colegas y amigos que facilita el trabajo conjunto, la generación de proyectos y el crecimiento de LATAM como región. Hasta el próximo #LEx2026!

Congratulations to our Chair Anna Sureda, as well as Steering Committee members Astrid Pavlovsky, Michelle Poon and Sonali Smith, for the recent publication of your article in the Lancet Haematology!!

Join us next week for the kickoff of our 14th webinar series "Demystifying Pharma"!

A huge THANK YOU to Michelle Dawson and Nina Shah for an incredible webinar yesterday! What a great way to kick off the series. Up next - Session 2 "Industry Engagement" with Clare Spooner, Suhaida Selamat and John Wahba. Register here: us06web.zoom.us/webinar/regist…

🌍 Powerful presentation at #EHA2025 on global gender equity in hematology . 🧭 Clear message: equity gaps are real—and fixable. Where there’s a WiL, there’s a way. 💪

Save the date! Our next webinar series will run throughout July - stay tuned for updates

#Hematology Epcoritamab Plus R-ICE Yields High CR Rates and Improves Transplant Eligibility in R/R DLBCL #EHA2025 #lymsm #lymphoma

Impressive response rates with #epcoritamab + R-ICE IN R/R DLBCL with ORR 87% and CR rate of 65%. Also in patients with early relapses within 12m 1L therapy #hematology #lymphoma #lymsm

(A) Two-year PFS in patients 60 years and older on S1826 by arm. (B) Two-year OS in patients 60 years and older on S1826 by arm. BV, brentuximab vedotin; HR, hazard ratio; N, nivolumab; OS, overall survival; PFS, progression-free survival. #lymsm #Hodgkin #lymphoma #geriheme

Together we lead, we learn, we lift each other up. Thank you to all who joined our WiL gathering at #18ICML — an inspiring evening filled with connection, purpose, and power. Let’s keep building this global community, one voice at a time. 🌍 #womeninhematology #ICML2025